News
Keeping tabs on pharma: First diabetes pill for pregnant women approved
March 07 by Leila HawkinsPharma IQ’s latest round-up includes a ground-breaking diabetes pill and the impact of Brexit on the medical devices market
Keeping tabs on Covid-19: Living with the virus
February 17 by Leila HawkinsThe UK is set to remove all Covid-19 rules in the coming days as the nation looks to return to normal, but around the world cases are still rising
Keeping tabs on pharma: Viagra-like drug shows promise in treating dementia
February 15 by Leila HawkinsNew research finds that a drug related to sildenafil could help treat dementia
Keeping tabs on pharma: UK hails “major step forward” in treating schizophrenia
February 08 by Leila HawkinsUK approves first long-acting new treatment for schizophrenia, Venus Remedies joins coalition to tackle anti-microbial resistance (AMR) and FDA resumes medical device inspections as Covid rates drop
Keeping tabs on pharma: New diabetes treatment for children and DMT studied for stroke patients
February 01 by Leila HawkinsA groundbreaking study shows great promise for children with diabetes, DMT research for stroke patients awaits approval and China tightens anti-monopoly laws
Keeping tabs on Covid-19: A mixed picture around the world
January 25 by Leila HawkinsOmicron peaks in some parts of Europe, but WHO warns this is not the end. Meanwhile Merck approves generic anti-viral for poorer nations
Keeping tabs on pharma: Novo Nordisk’s diabetes "game-changer" and the rise of antibiotic resistance
January 21 by Leila HawkinsIn Pharma IQ’s latest news bulletin: Novo Nordisk India’s ground-breaking diabetes pill, the threat of antibiotic resistance and a new nasal drug that could combat Covid-19
Keeping tabs on pharma: World’s first GMO heart transplant, new insomnia drug
January 14 by Leila HawkinsIn Pharma IQ’s latest news bulletin: the world’s first gene-edited pig’s heart transplant, and new drugs for insomnia and cystic fibrosis gain approval
FDA grants accelerated approval for first Alzheimer’s disease treatment
June 11 by Emily UwemedimoThe FDA has approved Biogen and Eisai’s Alzheimer’s disease drug aducanumab
Post-Brexit UK to continue role in EU’s €95.5bn research and innovation program
February 15 by Emily UwemedimoUK and EU trade agreement clears the way for the UK to continue a close scientific relationship with the EU and drive flagship pharma projects
Lung cancer progress halted by Covid-19 pandemic
January 28 by Emily UwemedimoThe pandemic’s strain on health and healthcare systems leads to growing calls from healthcare experts for global government cooperation
First commercial test announced to curb coronavirus pandemic
March 13 by Emily UwemedimoRoche has announced the first FDA Emergency Use Authorization commercial test to control further spread of the coronavirus